Difference between revisions of "Timeline of Schistosomiasis Control Initiative"
From Timelines
Line 42: | Line 42: | ||
|- | |- | ||
| 2013 || || Expansion || SCI begins first round of treatment in {{w|Ethiopia}} and {{w|Mauritania}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/><ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/> || {{w|Ethiopia}}, {{w|Mauritania}} | | 2013 || || Expansion || SCI begins first round of treatment in {{w|Ethiopia}} and {{w|Mauritania}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/><ref name="Schistosomiasis Control Initiative: Supplementary Information"/><ref name="OUR REACH"/> || {{w|Ethiopia}}, {{w|Mauritania}} | ||
+ | |- | ||
+ | | 2013 || || || A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in {{w|sub-Saharan Africa}} and only 12.7% receiving preventive chemotherapy.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty">{{cite journal |last1=Savioli |first1=Lorenzo |last2=Albonico |first2=Marco |last3=Colley |first3=Daniel G. |last4=Correa-Oliveira |first4=Rodrigo |last5=Fenwick |first5=Alan |last6=Green |first6=Will |last7=Kabatereine |first7=Narcis |last8=Kabore |first8=Achille |last9=Katz |first9=Naftale |last10=Klohe |first10=Katharina |last11=LoVerde |first11=Philip T. |last12=Rollinson |first12=David |last13=Russell Stothard |first13=J. |last14=Tchuem Tchuenté |first14=Louis-Albert |last15=Waltz |first15=Johannes |last16=Zhou |first16=Xiao-Nong |title=Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty |doi=10.1186/s40249-017-0280-8 |pmid=28330495 |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363045/ |pmc=5363045}}</ref> || | ||
|- | |- | ||
| 2013 – 2014 || Between November 2013 and April 2014 || || SCI funds mapping in {{w|Ethiopia}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}} | | 2013 – 2014 || Between November 2013 and April 2014 || || SCI funds mapping in {{w|Ethiopia}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}} |
Revision as of 08:38, 16 March 2019
This is a timeline of Schistosomiasis Control Initiative.
Contents
Big picture
Time period | Development summary | More details |
---|
Full timeline
Year | Month and date | Event type | Details | Location |
---|---|---|---|---|
2002 | SCI is founded through a US$32 million grant from the Bill and Melinda Gates Foundation[1], to tackle schistosomiasis in sub-Saharan Africa, where infected people are unable to afford the drugs needed for treatment.[2][3] | |||
2002 | SCI begins program in Uganda, the first operating country.[4] | Uganda | ||
2003 | October | SCI selects six countries for full support: Uganda, Burkina Faso, Niger, Mali, Tanzania, and Zambia. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.[5] | ||
2003 | SCI begins program in Zambia, Zanzibar, and Niger.[4] | Zambia, Zanzibar, Niger | ||
2006 | Funding | SCI receives large grants from the United States Agency for International Development and the Bill & Melinda Gates Foundation to support integrated NTD programs in eight countries for five years to treat lymphatic filariasis, onchocerciasis, and trachoma, in addition to schistosomiasis and soil-transmitted helminths.[1] | ||
2007 | Funding | SCI receives a grant to expand its work to Rwanda and Burundi.[1] | ||
2007 | SCI program starts in Burundi.[4] | Burundi | ||
2010 | SCI begins working in Côte d'Ivoire.[1] | Côte d'Ivoire | ||
2010 | SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[1] | |||
2010 | October | Funding | SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[6][1] | |
2011 | Expansion | SCI begins program in Liberia, Malawi, and Mozambique.[4] | Liberia, Malawi, Mozanbique | |
2012 | Expansion | SCI program starts in Côte d'Ivoire, two years later due to political turmoil.[1][4] | Côte d'Ivoire | |
2012 | Expansion | SCI begins conversations with the Government of Ethiopia about starting a national schistosomiasis treatment program.[1] | Ethiopia | |
2012 | Coverage | SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.[7] | ||
2013 | Expansion | SCI begins first round of treatment in Ethiopia and Mauritania.[1][4][1][4] | Ethiopia, Mauritania | |
2013 | A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in sub-Saharan Africa and only 12.7% receiving preventive chemotherapy.[8] | |||
2013 – 2014 | Between November 2013 and April 2014 | SCI funds mapping in Ethiopia.[1] | Ethiopia | |
2014 | Expansion | SCI begins program in the Democratic Republic of the Congo and Madagascar.[4] | Democratic Republic of the Congo, Madagascar | |
2014 | SCI begins working with other partners in Côte d'Ivoire, including Sightsavers, the END Fund, and Helen Keller International on a more integrated neglected tropical diseases (NTD) program.[1] | |||
2014 | Funding | The British Department for International Development awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.[1] | ||
2014 | Coverage | ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.[7] | ||
2014 – 2015 | Coverage | SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.[1] | Côte d'Ivoire | |
2015 | Coverage | ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.[7] | ||
2015 – 2016 | SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.[1] | |||
2015 – 2016 | Between April 2015 and March 2016 | SCI spends around US$2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia during the period.[1] | ||
2015 – 2016 | Between April 2015 and March 2016 | SCI reports having delivered 890,000 treatments in Uganda, out of 1.2 million planned treatments.[1] | ||
2011 | Expansion | SCI begins program in Nigeria.[4] | Nigeria | |
2016 | January | Funding | Private foundation Good Ventures awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from GiveWell in 2015.[9] | |
2016 | August | GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).[7] | ||
2017 | January | Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.[10] | ||
2017 | GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.[11] | |||
2018 | "In Q4 2017, GiveWell allocated 100% of its discretionary fund to the SCI, totalling $5.6 million. It allocated a further $0.89 million to the SCI in Q1 2018, which was 30% of its discretionary fund for that period."[11] |
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by User:Sebastian.
Funding information for this timeline is available.
Feedback and comments
Feedback for the timeline can be provided at the following places:
- FIXME
What the timeline is still missing
Timeline update strategy
See also
External links
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 "Schistosomiasis Control Initiative: Supplementary Information". givewell.org. Retrieved 11 March 2019.
- ↑ "Ten million Africans treated by international disease treatment programme". imperial.ac.uk. Retrieved 12 March 2019.
- ↑ Adenowoa, Abiola Fatimah; Oyinloyea, Babatunji Emmanuel; Ogunyinkaa, Bolajoko Idiat; Kappo, Abidemi Paul. "Impact of human schistosomiasis in sub-Saharan Africa". Brazilian Journal of Infectious Diseases. doi:10.1016/j.bjid.2014.11.004.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 "OUR REACH". schistosomiasiscontrolinitiative.org. Retrieved 12 March 2019.
- ↑ "Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016". givewell.org. Retrieved 12 March 2019.
- ↑ "Imperial initiative to protect children from tropical disease awarded £25m government backing". imperial.ac.uk. Retrieved 11 March 2019.
- ↑ 7.0 7.1 7.2 7.3 "SCHISTOSOMIASIS CONTROL INITIATIVE". givingwhatwecan.org. Retrieved 12 March 2019.
- ↑ Savioli, Lorenzo; Albonico, Marco; Colley, Daniel G.; Correa-Oliveira, Rodrigo; Fenwick, Alan; Green, Will; Kabatereine, Narcis; Kabore, Achille; Katz, Naftale; Klohe, Katharina; LoVerde, Philip T.; Rollinson, David; Russell Stothard, J.; Tchuem Tchuenté, Louis-Albert; Waltz, Johannes; Zhou, Xiao-Nong. "Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty". PMC 5363045. PMID 28330495. doi:10.1186/s40249-017-0280-8.
- ↑ "Schistosomiasis Control Initiative — General Support (2016)". openphilanthropy.org. Retrieved 11 March 2019.
- ↑ "Schistosomiasis Control Initiative — General Support (2017)". openphilanthropy.org. Retrieved 11 March 2019.
- ↑ 11.0 11.1 "HOW YOUR MONEY IS SPENT". schistosomiasiscontrolinitiative.org. Retrieved 15 March 2019.